Viewing Study NCT01602094


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-03-11 @ 7:00 AM
Study NCT ID: NCT01602094
Status: UNKNOWN
Last Update Posted: 2012-05-18
First Post: 2012-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
Sponsor: Queen Saovabha Memorial Institute
Organization:

Study Overview

Official Title: Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
Status: UNKNOWN
Status Verified Date: 2012-05
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Prevalence of participants who have protective immunity to measles virus is less than ninety percent.

Predictor of adequate measles antibody levels include the following :

* History of measles infection
* History of complete measles primary immunization( 2 doses with at least 1 month interval after age of 9 months)
* History of measles exposure

Predictor of inadequate measles antibody levels include the following :

* Born outside Thailand
* History of staying outside Thailand for long time in childhood
* Living in the rural area for a long period in childhood
* Fail to participate school system on time
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: